Changes in the spectrum of biopsy-proven renal diseases over 11 years: a single-center study in China

Background There have been some shifts in the frequency and distribution of biopsy-proven renal diseases in China over recent years. The aim of the study was to investigate the changing spectrum of renal diseases from the view of kidney biopsy data in a single center of China.Methods and results A t...

Full description

Saved in:
Bibliographic Details
Main Authors: Yujia Wang, Liyin Zhang, Li Yuan, Qionghong Xie, Shaojun Liu, Chuan-ming Hao
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Renal Failure
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2024.2381614
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850140106361405440
author Yujia Wang
Liyin Zhang
Li Yuan
Qionghong Xie
Shaojun Liu
Chuan-ming Hao
author_facet Yujia Wang
Liyin Zhang
Li Yuan
Qionghong Xie
Shaojun Liu
Chuan-ming Hao
author_sort Yujia Wang
collection DOAJ
description Background There have been some shifts in the frequency and distribution of biopsy-proven renal diseases in China over recent years. The aim of the study was to investigate the changing spectrum of renal diseases from the view of kidney biopsy data in a single center of China.Methods and results A total of 10,996 cases of native renal biopsies from patients aged ≥15 years old in Huashan Hospital, Fudan University, between 2008 and 2018 were analyzed retrospectively. The results showed that primary glomerular nephropathy (PGN) remained the most common biopsy-proven renal disease (69.42% of total), with IgA nephropathy (IgAN) accounting for 44.40% of PGN, membranous nephropathy (MN) for 28.55%, minimal change disease (MCD) for 13.26% and focal segmental glomerulosclerosis (FSGS) for 8.00%. During the study period, the proportion of MN in PGN appeared an increasing tendency, while that of IgAN and MCD remained stable and that of FSGS showed a decline. Secondary glomerular nephropathy (SGN) constituted 21.54% of total cases, among which the leading two diseases were lupus nephritis (LN) and Henoch-Schonlein purpura nephritis (HSN) which accounted for 41.08% and 19.11% respectively.Conclusions The 11-year retrospective study revealed that PGN was the predominant histologic diagnosis among patients undergoing renal biopsy and the most frequent type of PGN remained to be IgAN, followed by MN which increased dramatically.
format Article
id doaj-art-28b7cb8755ef46b0846269d812e8fb4a
institution OA Journals
issn 0886-022X
1525-6049
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj-art-28b7cb8755ef46b0846269d812e8fb4a2025-08-20T02:29:58ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492024-12-0146210.1080/0886022X.2024.2381614Changes in the spectrum of biopsy-proven renal diseases over 11 years: a single-center study in ChinaYujia Wang0Liyin Zhang1Li Yuan2Qionghong Xie3Shaojun Liu4Chuan-ming Hao5Department of Nephrology, Huashan Hospital, and Nephrology Research Institute, Fudan University, Shanghai, ChinaDepartment of Nephrology, Huashan Hospital, and Nephrology Research Institute, Fudan University, Shanghai, ChinaDepartment of Nephrology, Huashan Hospital, and Nephrology Research Institute, Fudan University, Shanghai, ChinaDepartment of Nephrology, Huashan Hospital, and Nephrology Research Institute, Fudan University, Shanghai, ChinaDepartment of Nephrology, Huashan Hospital, and Nephrology Research Institute, Fudan University, Shanghai, ChinaDepartment of Nephrology, Huashan Hospital, and Nephrology Research Institute, Fudan University, Shanghai, ChinaBackground There have been some shifts in the frequency and distribution of biopsy-proven renal diseases in China over recent years. The aim of the study was to investigate the changing spectrum of renal diseases from the view of kidney biopsy data in a single center of China.Methods and results A total of 10,996 cases of native renal biopsies from patients aged ≥15 years old in Huashan Hospital, Fudan University, between 2008 and 2018 were analyzed retrospectively. The results showed that primary glomerular nephropathy (PGN) remained the most common biopsy-proven renal disease (69.42% of total), with IgA nephropathy (IgAN) accounting for 44.40% of PGN, membranous nephropathy (MN) for 28.55%, minimal change disease (MCD) for 13.26% and focal segmental glomerulosclerosis (FSGS) for 8.00%. During the study period, the proportion of MN in PGN appeared an increasing tendency, while that of IgAN and MCD remained stable and that of FSGS showed a decline. Secondary glomerular nephropathy (SGN) constituted 21.54% of total cases, among which the leading two diseases were lupus nephritis (LN) and Henoch-Schonlein purpura nephritis (HSN) which accounted for 41.08% and 19.11% respectively.Conclusions The 11-year retrospective study revealed that PGN was the predominant histologic diagnosis among patients undergoing renal biopsy and the most frequent type of PGN remained to be IgAN, followed by MN which increased dramatically.https://www.tandfonline.com/doi/10.1080/0886022X.2024.2381614Kidney diseaseprimary glomerular nephropathysecondary glomerular nephropathyrenal biopsyChina
spellingShingle Yujia Wang
Liyin Zhang
Li Yuan
Qionghong Xie
Shaojun Liu
Chuan-ming Hao
Changes in the spectrum of biopsy-proven renal diseases over 11 years: a single-center study in China
Renal Failure
Kidney disease
primary glomerular nephropathy
secondary glomerular nephropathy
renal biopsy
China
title Changes in the spectrum of biopsy-proven renal diseases over 11 years: a single-center study in China
title_full Changes in the spectrum of biopsy-proven renal diseases over 11 years: a single-center study in China
title_fullStr Changes in the spectrum of biopsy-proven renal diseases over 11 years: a single-center study in China
title_full_unstemmed Changes in the spectrum of biopsy-proven renal diseases over 11 years: a single-center study in China
title_short Changes in the spectrum of biopsy-proven renal diseases over 11 years: a single-center study in China
title_sort changes in the spectrum of biopsy proven renal diseases over 11 years a single center study in china
topic Kidney disease
primary glomerular nephropathy
secondary glomerular nephropathy
renal biopsy
China
url https://www.tandfonline.com/doi/10.1080/0886022X.2024.2381614
work_keys_str_mv AT yujiawang changesinthespectrumofbiopsyprovenrenaldiseasesover11yearsasinglecenterstudyinchina
AT liyinzhang changesinthespectrumofbiopsyprovenrenaldiseasesover11yearsasinglecenterstudyinchina
AT liyuan changesinthespectrumofbiopsyprovenrenaldiseasesover11yearsasinglecenterstudyinchina
AT qionghongxie changesinthespectrumofbiopsyprovenrenaldiseasesover11yearsasinglecenterstudyinchina
AT shaojunliu changesinthespectrumofbiopsyprovenrenaldiseasesover11yearsasinglecenterstudyinchina
AT chuanminghao changesinthespectrumofbiopsyprovenrenaldiseasesover11yearsasinglecenterstudyinchina